Unable to load price data. Sorry.

¯\_(ツ)_/¯

Immune Pharmaceuticals, Inc. (NASDAQ:EPCT)

CAPS Rating: No stars

A pharmaceutical company focused on the development of pharmaceutical products for the treatment of cancer and pain.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

3 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EPCT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:EPCT VS S&P 500 (SPY)

Fools bullish on NASDAQ:EPCT are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about EPCT.

No one has written a Pitch for EPCT stock yet. Tell us why you think EPCT will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in EPCT.

Score Leader

RMITRA757

RMITRA757 (97.38) Score: +27.46

The Score Leader is the player with the highest score across all their picks in EPCT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
rwpaules 71.25 3/3/2011 Outperform 5Y $0.76 -50.14% +135.30% -185.45 0 Comment
rschwind 50.61 2/7/2011 Outperform 5Y $0.87 -56.20% +135.68% -191.87 0 Comment
libraboomer 28.39 2/17/2010 Outperform 3W $2.22 -82.93% +182.52% -265.46 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EPCT.